Sort
10,766 grants matching “checkpoint inhibitor”
Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
$79,250Robin Kate Kelley · University Of California, San Francisco · R03 · FY2017 · CA
Acoustic assembly of patient tumor organoids for modeling cancer immunity
$79,250Feng Guo · Trustees Of Indiana University · R03 · FY2021 · EB
Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
$79,250Robin Kate Kelley · University Of California, San Francisco · R03 · FY2018 · CA
Mitochondrial dynamics in human pulmonary hypertension: a new therapeutic target
$79,000Willard William Sharp · University Of Chicago · R03 · FY2012 · HL
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$78,847Clifford Cho · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Exploring mechanisms to increase cancer cell antigenicity by modulating lineage-specific transcription in tumors
$78,830Hans Ragnar Widlund · Brigham And Women'S Hospital · R03 · FY2017 · CA
Validation of OXPHOS gene amplification as a driver of hypoxia and treatment resistance in NSCLC
$78,750Martin Benej · Ohio State University · R03 · FY2023 · CA
Validation of OXPHOS gene amplification as a driver of hypoxia and treatment resistance in NSCLC
$78,750Martin Benej · Ohio State University · R03 · FY2024 · CA
Deubiquitinases in Cell Cycle Control
$78,554Michael James Emanuele · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM
Targeting MCL-1 dependent apoptotic vulnerability of KRAS-LKB1 NSCLC
$78,550Chendi Li · Massachusetts General Hospital · F32 · FY2022 · CA
Human Biophysiology Shared Resource
$78,324Michelle C Janelsins · University Of Rochester · P30 · FY2025 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$78,223John Tanner Wilson · Vanderbilt University · R01 · FY2024 · EB
Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells
$78,000Maria Isabel Ramirez · Thomas Jefferson University · R03 · FY2022 · CA
The Mechanism of Lung Chemoprevention Mediated by ITCs
$78,000New York Medical College · R03 · FY2004 · CA
Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells
$78,000Maria Isabel Ramirez · Thomas Jefferson University · R03 · FY2021 · CA
Genetically engineered mouse models to investigate the liposarcoma microenvironment
$78,000Christina Vadala Angeles · University Of Michigan At Ann Arbor · R03 · FY2024 · CA
The Mechanism of Lung Chemoprevention Mediated by ITCs
$78,000New York Medical College · R03 · FY2005 · CA
Genetically engineered mouse models to investigate the liposarcoma microenvironment
$78,000Christina Vadala Angeles · University Of Michigan At Ann Arbor · R03 · FY2025 · CA
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-positive and HPV-negative Penile Cancer
$77,754Curtis Pettaway · University Of Tx Md Anderson Can Ctr · U54 · FY2020 · CA
Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis
$77,639Alfred Ayala · Rhode Island Hospital · R35 · FY2022 · GM
Apoptosis in Postmitotic Cells: Increased Regulation and Novel Checkpoints
$77,591Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2009 · GM
Antitumor-Antibiotics from Marine Microorganisms
$77,500William Fenical · University Of California, San Diego · R37 · FY2012 · CA
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy
$77,500Michael Nathan Vansaun · University Of Kansas Medical Center · R03 · FY2024 · CA
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy
$77,500Michael Nathan Vansaun · University Of Kansas Medical Center · R03 · FY2025 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$77,375Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2024 · CA